Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Chemomab Therapeutics (CMMB) EPS (Basic) (2017 - 2025)

Chemomab Therapeutics posted quarterly EPS (Basic) of $0.0 for Q4 2025, down 62.5% year-on-year from $0.01 in Q4 2024, and down 25.0% on a QoQ basis from $0.0 in Q3 2025.

Chemomab Therapeutics (CMMB) has 9 years of EPS (Basic) data on file, last reported at $0.0 in Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) fell 62.5% year-over-year to $0.0; the trailing twelve-month figure through Dec 2025 stood at $0.02 (down 66.67% YoY), and the FY2025 full-year result was $0.02, down 53.85% from the prior year.
  • EPS (Basic) for Q4 2025 stood at $0.0, down from $0.0 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.04 in Q1 2023 and bottomed at $0.0 in Q4 2025.
  • The 5-year median for EPS (Basic) is $0.01 (2024), against an average of $0.02.
  • The widest annual swing landed in 2022, when EPS (Basic) soared 169.23%; it then plunged 65.0% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at $0.02 in 2021, then soared by 63.64% to $0.04 in 2022, then tumbled by 59.61% to $0.01 in 2023, then plunged by 44.98% to $0.01 in 2024, then sank by 62.5% to $0.0 in 2025.
  • The last three EPS (Basic) figures came in at $0.0 (Q4 2025), $0.0 (Q3 2025), and $0.01 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.06
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 0.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 4.06
7 Evaxion A 62.56 Bn 62.54 Bn - 0.00
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 6.99
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.55
10 Chemomab Therapeutics 959.23 Mn 948.86 Mn - 0.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Dec 31, 2024 0.01
Sep 30, 2024 0.01
Jun 30, 2024 0.01
Mar 31, 2024 0.01
Dec 31, 2023 0.01
Jun 30, 2023 0.04
Mar 31, 2023 0.04
Dec 31, 2022 0.04
Sep 30, 2022 0.04
Jun 30, 2022 0.03
Mar 31, 2022 0.02
Dec 31, 2021 0.02
Sep 30, 2021 0.01
Jun 30, 2021 0.01
Mar 31, 2021 0.01
Dec 31, 2020 0.01
Sep 30, 2020 0.01
Jun 30, 2020 0.01
Mar 31, 2020 0.01
Dec 31, 2019 1.43
Sep 30, 2019 -0.19
Jun 30, 2019 -0.12
Mar 31, 2019 -0.38
Dec 31, 2018 0.11
Sep 30, 2018 0.17
Jun 30, 2018 0.55
Dec 31, 2017 0.20